Clover Health Investments price to book ratio CLOV
Market value divided by the book value of the company's net assets, since 2021.
- Today, Oct 23, 2026
- 6.5×
- 6-year median
- 3.4×
- Against its 6-year history
- 87th
- percentile: 0 is its lowest day, 100 its highest
- 6-year range
- 1.0× to 195×
- Peer median
- 4.7×
Clover Health Investments' price to book ratio is 6.5× as of Oct 23, 2026.
That is above its 6-year median of 3.4×, higher than on 87% of days in the last 6 years.
Over that time it ranged from 1.0× in Apr 2023 to 195× in Feb 2021.
The median for 3 health insurers of a similar size is 4.7×.
Price to book ratio over time
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 6.5× | 2.9× | 8.4× |
| 2025 | 3.8× | 3.2× | 7.1× |
| 2024 | 4.8× | 1.1× | 6.4× |
| 2023 | 1.4× | 1.0× | 2.2× |
| 2022 | 1.1× | 1.1× | 3.7× |
| 2021 | 3.8× | 3.8× | 195× |
Against its peers
Companies in Medical - Healthcare Plans nearest Clover Health Investments' size, closest first, today.
| Company | Price to book ratio |
|---|---|
| CLOVClover Health Investments | 6.5× |
| ALHCAlignment Healthcare | 6.3× |
| TRUPTrupanion | 3.1× |
| OSCROscar Health | 4.7× |
| Peer median | 4.7× |
What the price to book ratio tells you
Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.
Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.
More on Clover Health Investments
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.